Dana Farber Cancer Hospital ( Site 0155) — Boston, Massachusetts

Dana Farber Cancer Hospital ( Site 0155) is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Hospital ( Site 0155) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Hospital ( Site 0155)?

Dana Farber Cancer Hospital ( Site 0155) has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Hospital ( Site 0155) conducted?

Dana Farber Cancer Hospital ( Site 0155) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Dana Farber Cancer Hospital ( Site 0155) accredited by Crixeo Clinical Trials?

Dana Farber Cancer Hospital ( Site 0155) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Hospital ( Site 0155)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.